Immunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Mucosal Immunol. 2019 May;12(3):703-719. doi: 10.1038/s41385-018-0126-0. Epub 2019 Jan 22.
Inflammatory bowel diseases are associated with dysregulated immune responses in the intestinal tissue. Four molecularly identified macrophage subsets control immune homeostasis in healthy gut. However, the specific roles and transcriptomic profiles of the phenotypically heterogeneous CD14 macrophage-like population in inflamed gut remain to be investigated in Crohn's disease (CD). Here we identified two phenotypically, morphologically and functionally distinct colonic HLADRSIRPαCD14 subpopulations that were further characterized using single-cell RNA-sequencing (scRNAseq) in CD. Frequencies of CD64CD163 cells selectively augmented in inflamed colon and correlated with endoscopic score of disease severity. IL-1β and IL-23-producing CD64CD163 cells predominated over TNF-α-producing CD64CD163 cells in lesions. Purified "inflammatory monocyte-like" CD163, but not "macrophage-like" CD163 cells, through IL-1β, promoted Th17/Th1 but not Th1 responses in tissue memory CD4T cells. Unsupervised scRNAseq analysis that captures the entire HLADRSIRPα population revealed six clusters, two of which were enriched in either CD163 or CD163 cells, and best defined by TREM1/FCAR/FCN1/IL1RN or CD209/MERTK/MRCI/CD163L1 genes, respectively. Selected newly identified discriminating markers were used beyond CD163 to isolate cells that shared pro-Th17/Th1 function with CD163 cells. In conclusion, a molecularly distinct pro-inflammatory CD14 subpopulation accumulates in inflamed colon, drives intestinal inflammatory T-cell responses, and thus, might contribute to CD disease severity.
炎症性肠病与肠道组织中免疫反应失调有关。四种分子上鉴定的巨噬细胞亚群控制着健康肠道中的免疫稳态。然而,在克罗恩病(CD)中,表型异质性 CD14 样巨噬细胞群体在发炎肠道中的具体作用和转录组特征仍有待研究。在这里,我们鉴定了两种表型、形态和功能不同的结肠 HLA-DR/SIRPα/CD14 亚群,并用 CD 中的单细胞 RNA 测序(scRNA-seq)进一步进行了特征描述。在发炎的结肠中,CD64CD163 细胞的频率选择性增加,并与疾病严重程度的内镜评分相关。病变中主要存在产生 IL-1β 和 IL-23 的 CD64CD163 细胞,而不是产生 TNF-α 的 CD64CD163 细胞。通过 IL-1β,纯化的“炎症单核细胞样” CD163,但不是“巨噬细胞样” CD163 细胞,促进组织记忆 CD4T 细胞中的 Th17/Th1 反应,但不是 Th1 反应。捕获整个 HLA-DR/SIRPα 群体的无监督 scRNA-seq 分析揭示了六个簇,其中两个簇分别富含 CD163 或 CD163 细胞,分别由 TREM1/FCAR/FCN1/IL1RN 或 CD209/MERTK/MRCI/CD163L1 基因最佳定义。选择新鉴定的有区别的标记物不仅用于 CD163 来分离与 CD163 细胞具有共同的促 Th17/Th1 功能的细胞。总之,在发炎的结肠中积累了一种分子上不同的促炎 CD14 亚群,它驱动肠道炎症性 T 细胞反应,因此可能有助于 CD 疾病的严重程度。